In America alone, over 800,000 people suffer from stroke every year, with over 140,000 of those patients dying from their stroke. Even for those who survive stroke, life is never the same. Many people never fully recover from their stroke, suffering from loss of use of one or more limbs, and working hard to learn [Read More]
Stemedica Cell Technologies are reporting that using ischemic tolerant mesenchymal stem cells (itMSCs) to treat ischemic stroke is safe, well-tolerated, and shows preliminary signs of efficacy in an open-label Phase I/IIa trial. This treatment, which is also being developed for treating Alzheimer’s disease, could begin Phase IIb trials in the near future (1). Ischemic Stroke [Read More]
Leonarda McCourt, a 77-year-old great grandfather from Newcastle in the United Kingdom participated in the world’s first regulated stem cell study for patients who have suffered a stroke. One of only 21 patients enrolled in the trial, McCourt received a direct injection of stem cells into his brain in 2016. This is a pioneering treatment [Read More]
Close to 800,000 Americans are struck by a stroke each year. Depending on the severity and how much of the brain is affected, the damage can be temporary or permanent. Following stroke, rehabilitation can help healthy brain cells take over the function of cells that were damaged due to the lack of blood supply. However, [Read More]
